Jennifer K. Simpson
2020 - Panbela Therapeutics
In 2020, Jennifer K. Simpson earned a total compensation of $1.7M as President and Chief Executive Officer at Panbela Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $78,750 |
---|---|
Option Awards | $1,507,025 |
Salary | $145,587 |
Total | $1,731,362 |
Simpson received $1.5M in option awards, accounting for 87% of the total pay in 2020.
Simpson also received $78.8K in non-equity incentive plan and $145.6K in salary.
Rankings
In 2020, Jennifer K. Simpson's compensation ranked 6,200th out of 13,090 executives tracked by ExecPay. In other words, Simpson earned more than 52.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,200 | 53rd |
Manufacturing | 2,560 | 55th |
Chemicals And Allied Products | 1,031 | 54th |
Drugs | 890 | 55th |
Pharmaceutical Preparations | 664 | 55th |
Simpson's colleagues
We found two more compensation records of executives who worked with Jennifer K. Simpson at Panbela Therapeutics in 2020.
News
Panbela Therapeutics CEO Jennifer Simpson's 2021 pay jumps 372% to $1.2M
April 29, 2022
Panbela Therapeutics CEO Jennifer Simpson's 2020 pay jumps 62% to $1.7M
April 15, 2021
Delcath Systems CEO Gerard Michel's 2020 pay jumps 150% to $5.8M
April 7, 2021
Delcath Systems CEO Jennifer Simpson's 2019 pay jumps 97% to $1.1M
November 2, 2020
Delcath Systems CEO Jennifer Simpson's 2018 pay slips 11% to $542K
August 19, 2019